In a Securities and Exchange Commission report filed Thursday, Zymergen revealed it is cutting 80 more jobs and parting ways with Zach Serber, its co-founder and chief scientific officer, on Sept. 22.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,